Antioxidant therapy for severe sepsis: Promise and perspective *
- 1 November 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 31 (11), 2697-2698
- https://doi.org/10.1097/01.ccm.0000089942.54922.ff
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis*Critical Care Medicine, 2003
- Mitochondrial Membrane Potential and Apoptosis Peripheral Blood Monocytes in Severe Human SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.JCI Insight, 1997
- Cytopathic hypoxia in sepsisActa Anaesthesiologica Scandinavica, 1997
- Plasma antioxidant potential in severe sepsisCritical Care Medicine, 1996
- Sepsis/septic shockCritical Care Medicine, 1996
- Natural Cytokine Antagonists and Endogenous Antiendotoxin Core Antibodies in Sepsis SyndromeJAMA, 1995
- Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunctionCritical Care Medicine, 1995
- Free radicals and antioxidants in sepsisCritical Care Medicine, 1993